Cerner Co. (NASDAQ:CERN) saw unusually large options trading activity on Tuesday. Traders bought 3,425 put options on the stock. This is an increase of approximately 859% compared to the average volume of 357 put options.

Several research analysts recently commented on CERN shares. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Cerner in a research note on Wednesday, October 25th. SunTrust Banks reissued a “buy” rating and set a $79.00 target price on shares of Cerner in a research report on Thursday, October 19th. Zacks Investment Research raised shares of Cerner from a “hold” rating to a “buy” rating and set a $81.00 target price on the stock in a research report on Tuesday, October 17th. Jefferies Group set a $79.00 target price on shares of Cerner and gave the company a “buy” rating in a research report on Friday, October 13th. Finally, Piper Jaffray Companies reissued a “buy” rating and set a $77.00 target price on shares of Cerner in a research report on Thursday, October 12th. One investment analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have given a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $69.50.

In related news, CFO Marc G. Naughton sold 60,000 shares of the firm’s stock in a transaction dated Thursday, November 30th. The shares were sold at an average price of $70.64, for a total value of $4,238,400.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Clifford W. Illig sold 140,000 shares of the firm’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $65.52, for a total transaction of $9,172,800.00. Following the completion of the transaction, the chief executive officer now directly owns 1,229,719 shares in the company, valued at approximately $80,571,188.88. The disclosure for this sale can be found here. Insiders sold a total of 833,470 shares of company stock worth $55,418,902 in the last ninety days. 13.11% of the stock is currently owned by insiders.

Several large investors have recently added to or reduced their stakes in the company. AXA boosted its holdings in shares of Cerner by 7.1% in the 3rd quarter. AXA now owns 953,078 shares of the company’s stock valued at $67,974,000 after buying an additional 63,417 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new stake in shares of Cerner in the 3rd quarter valued at about $128,000. Archford Capital Strategies LLC boosted its holdings in shares of Cerner by 1,286.0% in the 3rd quarter. Archford Capital Strategies LLC now owns 2,980 shares of the company’s stock valued at $213,000 after buying an additional 2,765 shares in the last quarter. Moors & Cabot Inc. bought a new stake in shares of Cerner in the 3rd quarter valued at about $221,000. Finally, IFM Investors Pty Ltd bought a new stake in shares of Cerner in the 3rd quarter valued at about $629,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Shares of Cerner (NASDAQ CERN) opened at $69.94 on Friday. Cerner has a 1-year low of $47.01 and a 1-year high of $73.86. The firm has a market cap of $23,298.96, a PE ratio of 31.01, a PEG ratio of 2.26 and a beta of 0.94. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75.

Cerner (NASDAQ:CERN) last released its quarterly earnings results on Thursday, October 26th. The company reported $0.61 earnings per share for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). Cerner had a net margin of 13.37% and a return on equity of 18.03%. The firm had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same quarter in the prior year, the business posted $0.59 earnings per share. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. sell-side analysts predict that Cerner will post 2.25 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/08/cerner-target-of-unusually-large-options-trading-cern.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.